Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception: a Cochrane systematic review

BACKGROUND: The coronavirus disease COVID-19 is associated with an increased risk of thrombotic events. Individuals with COVID-19 using hormonal contraception could be at additional risk for thromboembolism, but evidence is sparse. METHODS: We conducted a systematic review on the risk of thromboembo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hansen, Katie, Cohen, Megan A, Ramanadhan, Shaalini, Paynter, Robin, Edelman, Alison, Henderson, Jillian T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359512/
https://www.ncbi.nlm.nih.gov/pubmed/36882324
http://dx.doi.org/10.1136/bmjsrh-2023-201792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359512/
https://www.ncbi.nlm.nih.gov/pubmed/36882324
http://dx.doi.org/10.1136/bmjsrh-2023-201792

Ejemplares similares